Related Experiment Video
Updated: Jun 4, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
In Vitro Model of Hypoxically Induced Nonreplicating Persistence of Mycobacterium tuberculosis
1Tubercolosis Research Laboratory, Department of Veterans Affairs Medical Centre, Long Beach, CA.
Tuberculosis control has stalled due to Mycobacterium tuberculosis's ability to enter a dormant state. This persistent infection challenges eradication efforts despite advances in immunology and chemotherapy.
Area of Science:
- Immunology
- Microbiology
- Infectious Diseases
Background:
- Significant advancements in tuberculosis (TB) immunology and chemotherapy occurred in the late 20th century.
- The human host is the primary ecological niche for Mycobacterium tuberculosis, suggesting potential for eradication.
- Periodic resurgences of TB indicate limitations in current control strategies.
Purpose of the Study:
- To investigate the factors contributing to the resurgence of tuberculosis.
- To understand the mechanisms by which Mycobacterium tuberculosis persists despite host immunity and treatment.
Main Methods:
- Review of immunological and chemotherapeutic strategies for TB management.
- Analysis of the ecologic niche of Mycobacterium tuberculosis.
- Examination of the host-pathogen interaction in persistent TB infections.
Main Results:
- Despite progress, TB eradication has not been achieved due to disease resurgence.
- Socioeconomic factors contribute to TB persistence.
- Mycobacterium tuberculosis can enter a quiescent state, evading immune responses and chemotherapy.
Conclusions:
- The ability of Mycobacterium tuberculosis to persist in a quiescent state is a critical factor hindering TB eradication.
- Further research into TB dormancy and host-pathogen interactions is necessary.
- Novel strategies are required to overcome persistent infections and achieve TB control.
More Related Videos
09:57Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
Published on: December 14, 2016
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis